Esprit Pharma, Inc.

2525 Dupont Drive,
Irvine, California 92612
United States,

Esprit is a U.S.-based pharmaceutical company focused on the genitourinary (GU) and women’s healthcare markets. Esprit currently markets SANCTURA® (trospium chloride) for the treatment of overactive bladder (OAB), as well as ESTRASORB® (estradiol topical emulsion) for vaso-motor symptoms associated with menopause. In addition, Esprit controls marketing rights to the recently approved SANCTURA® XR, a novel, once-daily formulation of trospium chloride that has demonstrated outstanding clinical results in terms of efficacy and tolerability in the treatment of OAB.

Esprit Pharma was acquired by Allergan on September 19, 2007.

Join Mergr to view all 206 acquisitions of healthcare services companies in 2007, including 79 acquisitions by private equity firms, and 127 by strategics.

Out of 60 sectors in the Mergr database, healthcare services ranked 5 in number of deals in 2007. The largest healthcare services acquisition in 2007 was HCR ManorCare - which was acquired by The Carlyle Group for $6.3B.

Join Mergr to view this profile - and discover more healthcare services acquisitions of companies like Esprit Pharma.

What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 3.4K Private Equity Firms
  • 119K M&A Transactions
  • 129K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.